Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 617

1.

[Treatment of osteoporosis in the elderly: what is the evidence?].

Verhaar HJ.

Tijdschr Gerontol Geriatr. 2008 Oct;39(5):168-75. Dutch.

PMID:
18975841
2.

Medical treatment of osteoporosis in the elderly.

Verhaar HJ.

Aging Clin Exp Res. 2009 Dec;21(6):407-13.

PMID:
20154509
3.
4.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
5.

Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.

[No authors listed]

Prescrire Int. 2005 Dec;14(80):207-11.

PMID:
16397977
6.

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

Inderjeeth CA, Foo AC, Lai MM, Glendenning P.

Bone. 2009 May;44(5):744-51. doi: 10.1016/j.bone.2008.12.003. Epub 2008 Dec 16. Review.

PMID:
19130909
7.

Pharmacologic prevention of osteoporotic fractures.

Zizic TM.

Am Fam Physician. 2004 Oct 1;70(7):1293-300. Review.

8.

Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.

Boonen S, Marin F, Mellstrom D, Xie L, Desaiah D, Krege JH, Rosen CJ.

J Am Geriatr Soc. 2006 May;54(5):782-9.

PMID:
16696744
9.

Antiresorption therapy and reduction in fracture susceptibility in the osteoporotic elderly patient: open study.

Muscoso E, Puglisi N, Mamazza C, Lo Giudice F, Testai M, Abbate S, Santangelo A, Panebianco P, Maugeri D.

Eur Rev Med Pharmacol Sci. 2004 Mar-Apr;8(2):97-102.

PMID:
15267123
10.

Prevention of osteoporosis and fractures.

Ullom-Minnich P.

Am Fam Physician. 1999 Jul;60(1):194-202. Review.

11.

Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study.

Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, Agnusdei D, Iori N, Nuti R; ICARO Study Group.

J Bone Miner Res. 2006 Oct;21(10):1565-70.

12.

Treatment of osteoporosis with parathyroid hormone and teriparatide.

Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K.

Calcif Tissue Int. 2009 Mar;84(3):159-70. doi: 10.1007/s00223-009-9218-x. Epub 2009 Feb 3. Review. Erratum in: Calcif Tissue Int. 2009 Nov;85(5):463.

PMID:
19189037
13.

The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.

Fleurence RL, Iglesias CP, Johnson JM.

Pharmacoeconomics. 2007;25(11):913-33. Review.

PMID:
17960951
14.

Osteoporosis prevention and treatment.

Sambrook PN, Eisman JA.

Med J Aust. 2000 Mar 6;172(5):226-9. Review.

PMID:
10776395
16.

Pharmacologic therapy for the treatment and prevention of osteoporosis.

McClung B, McClung M.

Nurs Clin North Am. 2001 Sep;36(3):433-40, viii. Review.

PMID:
11532658
17.

[Osteoporosis in the elderly--diagnosis and treatment].

Gärtner R.

MMW Fortschr Med. 2005 Feb 17;147(7):33, 35-6. Review. German.

PMID:
18441582
18.

Osteoporosis in elderly: prevention and treatment.

Srivastava M, Deal C.

Clin Geriatr Med. 2002 Aug;18(3):529-55. Review.

PMID:
12424871
19.

[Therapeutic strategies for osteoporosis].

Chapurlat R, Delmas PD.

Ann Med Interne (Paris). 2000 Oct;151(6):471-6. Review. French.

PMID:
11104926
20.

[Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].

Lems WF, Hamdy NA, Netelenbos JC.

Ned Tijdschr Geneeskd. 2006 Jan 21;150(3):132-7. Review. Dutch.

PMID:
16463613

Supplemental Content

Support Center